AstraZeneca PLC (NASDAQ:AZN)
| 50.99 Delayed Data As of 4:00pm ET |  -1.50 / -2.86%Today’s Change | 36.15 Today|||52-Week Range 64.94 | +2.27% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 52.49 |
| Today’s open | 51.92 |
| Day’s range | 50.91 - 51.95 |
| Volume | 331,391 |
| Average volume (3 months) | 5,897,689 |
| Market cap | $136.5B |
Data as of 4:00pm ET, 10/28/2020
Growth & Valuation
| Earnings growth (last year) | -39.32% |
| Earnings growth (this year) | +13.85% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | +11.03% |
| P/E ratio | 62.2 |
| Price/Sales | 5.30 |
| Price/Book | 10.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMYBristol-Myers Squibb | -0.96 | -1.63% |
| ABBVAbbVie | -2.20 | -2.66% |
| LLYEli Lilly and Co | +0.60 | +0.45% |
| NVONovo Nordisk | -1.40 | -2.06% |
Data as of 5:33pm ET, 10/28/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | $0.50 |
| Annual revenue (last year) | $24.5B |
| Annual profit (last year) | $1.3B |
| Net profit margin | 5.47% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
